"Something has to give with drug pricing," said Philip Moeller, the author of "Get What's Yours for Medicare," a new book published by Simon & Schuster (which is owned by CBS, the parent company of CBS MoneyWatch). "I'm not saying the only way to solve this is to give Medicare the right to negate drug prices, but it's fundamentally unfair for U.S. consumers to pay virtually all the global share of R&D in our drug prices."

This site contains consumer research and information related to Medicare drug plans and is independently developed and operated by
PharmacyChecker.com. It is not associated with, endorsed or authorized by any part of the U.S. government. If you would like the official government website for Medicare, visit www.medicare.gov.